These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

81 related items for PubMed ID: 21563238

  • 1. Early versus late GD-DTPA MRI enhancement in experimental glioblastomas.
    Farace P, Tambalo S, Fiorini S, Merigo F, Daducci A, Nicolato E, Conti G, Degrassi A, Sbarbati A, Marzola P.
    J Magn Reson Imaging; 2011 Mar; 33(3):550-6. PubMed ID: 21563238
    [Abstract] [Full Text] [Related]

  • 2. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J, Xu YK, Liu X, Lü GS.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [Abstract] [Full Text] [Related]

  • 3. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ, Guo GJ, Zeng MS, Lü YC, Liu XW, Cui CY, Wu PH, Li L.
    Zhonghua Yi Xue Za Zhi; 2007 Jan 23; 87(4):240-3. PubMed ID: 17425867
    [Abstract] [Full Text] [Related]

  • 4. An assessment of the effectiveness of magnetic resonance imaging in delayed sequences after administration of Gd-DTPA contrast in the detection of metastatic lesions in the brain.
    Grzesiakowska U, Tacikowska M.
    Med Sci Monit; 2002 Jan 23; 8(1):MT21-4. PubMed ID: 11782684
    [Abstract] [Full Text] [Related]

  • 5. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A, Nitta N, Ohta S, Nitta-Seko A, Murata S, Jo J, Tabata Y, Takahashi M, Tani T, Murata K.
    J Magn Reson Imaging; 2009 Oct 23; 30(4):907-10. PubMed ID: 19787744
    [Abstract] [Full Text] [Related]

  • 6. MR findings of focal eosinophilic liver disease using gadoxetic acid.
    Lee J, Park CM, Kim KA, Lee CH, Choi JW.
    Magn Reson Imaging; 2010 Nov 23; 28(9):1327-34. PubMed ID: 20800984
    [Abstract] [Full Text] [Related]

  • 7. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
    Jin J, Teng G, Feng Y, Wu Y, Jin Q, Wang Y, Wang Z, Lu Q, Jiang Y, Wang S, Chen F, Marchal G, Ni Y.
    Cardiovasc Intervent Radiol; 2007 Nov 23; 30(2):248-56. PubMed ID: 17216375
    [Abstract] [Full Text] [Related]

  • 8. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA (Gd-EOB-DTPA)-enhanced hepatic MR imaging?
    Haradome H, Grazioli L, Tsunoo M, Tinti R, Frittoli B, Gambarini S, Morone M, Motosugi U, Colagrande S.
    J Magn Reson Imaging; 2010 Aug 23; 32(2):334-40. PubMed ID: 20677259
    [Abstract] [Full Text] [Related]

  • 9. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)].
    Fang YX.
    Zhonghua Yi Xue Za Zhi; 1989 Jun 23; 69(6):305-7, 22. PubMed ID: 2804747
    [Abstract] [Full Text] [Related]

  • 10. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
    Ulmer S, Helle M, Jansen O, Mehdorn HM, Nabavi A.
    Neuroimage; 2009 Mar 01; 45(1):38-43. PubMed ID: 19100843
    [Abstract] [Full Text] [Related]

  • 11. Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging.
    Gaustad JV, Benjaminsen IC, Graff BA, Brurberg KG, Ruud EB, Rofstad EK.
    J Magn Reson Imaging; 2005 Jun 01; 21(6):792-800. PubMed ID: 15906326
    [Abstract] [Full Text] [Related]

  • 12. Enhancing lesions of the brain: intraindividual crossover comparison of contrast enhancement after gadobenate dimeglumine versus established gadolinium comparators.
    Essig M, Tartaro A, Tartaglione T, Pirovano G, Kirchin MA, Spinazzi A.
    Acad Radiol; 2006 Jun 01; 13(6):744-51. PubMed ID: 16679277
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S, de Lussanet QG, van Genderen MH, Meijer EW, Beets-Tan RG, Griffioen AW, van Engelshoven JM, Backes WH.
    NMR Biomed; 2006 Feb 01; 19(1):133-41. PubMed ID: 16450331
    [Abstract] [Full Text] [Related]

  • 14. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
    Karam AR, Shankar S, Surapaneni P, Kim YH, Hussain S.
    J Magn Reson Imaging; 2010 Aug 01; 32(2):341-4. PubMed ID: 20677260
    [Abstract] [Full Text] [Related]

  • 15. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas?
    Pauleit D, Langen KJ, Floeth F, Hautzel H, Riemenschneider MJ, Reifenberger G, Shah NJ, Müller HW.
    J Magn Reson Imaging; 2004 Nov 01; 20(5):758-64. PubMed ID: 15503327
    [Abstract] [Full Text] [Related]

  • 16. Dynamic contrast-enhanced magnetic resonance imaging of human melanoma xenografts with necrotic regions.
    Gaustad JV, Benjaminsen IC, Ruud EB, Rofstad EK.
    J Magn Reson Imaging; 2007 Jul 01; 26(1):133-43. PubMed ID: 17659570
    [Abstract] [Full Text] [Related]

  • 17. The efficacy of gadobenate dimeglumine (Gd-BOPTA) at 3 Tesla in brain magnetic resonance imaging: comparison to 1.5 Tesla and a standard gadolinium chelate using a rat brain tumor model.
    Runge VM, Biswas J, Wintersperger BJ, Baumann SS, Jackson CB, Herborn CU, Patel T.
    Invest Radiol; 2006 Mar 01; 41(3):244-8. PubMed ID: 16481906
    [Abstract] [Full Text] [Related]

  • 18. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B, Liang CH, Liu HJ, Wang GY, Zhang SX.
    Acta Radiol; 2010 Feb 01; 51(1):78-84. PubMed ID: 19912078
    [Abstract] [Full Text] [Related]

  • 19. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
    Kobayashi H, Saga T, Kawamoto S, Sato N, Hiraga A, Ishimori T, Konishi J, Togashi K, Brechbiel MW.
    Cancer Res; 2001 Jul 01; 61(13):4966-70. PubMed ID: 11431325
    [Abstract] [Full Text] [Related]

  • 20. A Magnetic Resonance comparative study between enhancement, rCBV and ACD in brain glioblastomas.
    Aprile I, Muti M, Principi M, Bartolini N, Zenoni A, Tazza G, Italiani M, Ottaviano P.
    Radiol Med; 2002 Jul 01; 104(1-2):87-91. PubMed ID: 12386559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.